Latest United States News

RMA Global has replaced its chief executive and moved to a new chair as it targets a simpler, faster and more profitable business across Australia, New Zealand and the United States. The company has set an EBITDA improvement objective for FY27, but has not yet quantified the plan.

Stakk has secured a live signature verification engagement for use by the United States Federal Bureau of Investigation through ParaScript, with the agreement running to December 2027. The company says the contract will contribute meaningfully to its FY2027 revenue target, now expected to exceed $55 million, although its value remains confidential.

Argent BioPharma has secured exclusive commercialisation rights to selected Tollovir, Tollovid and NutraVir antiviral products in a worldwide deal excluding China. The agreement adds a new commercial pillar alongside CimetrA®, but does not itself grant pharmaceutical development rights or establish clinical efficacy.

Perenti has secured drilling contracts across Australia, the United States and Canada expected to contribute about A$185 million in FY27 revenue, alongside an initial A$20 million underground development award in Senegal. A larger Sabodala-Massawa production phase remains conditional on Endeavour Mining issuing a notice to proceed.

Cynata Therapeutics (ASX:CYP) has reported a $9.25 million loss, negative net assets and a material uncertainty over going concern after its two major clinical trials failed to demonstrate efficacy. The company has since cut its workforce to zero, shifted management to the board and secured a $600,000 R&D tax incentive loan while it considers the future of its Cymerus platform.

Fulcrum Lithium has delivered a 10.7 million tonne lithium carbonate equivalent maiden resource at Alkali Flats, but its auditor has warned that additional funding is needed to sustain exploration. Cash fell to $1.58 million at 30 June 2026 as the company advanced drilling, metallurgy and resource modelling in Nevada.

Brazilian Critical Minerals has reported striking economics for its Ema rare earths project, including a US$1.47 billion post-tax NPV, 105% IRR and six-month payback. The company’s A$7.87 million FY2026 loss, December debt maturity, permitting requirements and unresolved Drake dispute leave the development case dependent on execution and further funding.

Cobalt Blue has secured a US$150,000 contract to deliver key technical work for Glomar Minerals’ planned US polymetallic nodule refinery. The work takes Project Infinity into a formal Preliminary Economic Analysis, although the project remains at an early evaluation stage and its cost estimates carry a wide accuracy range.

Element 25 has moved its Butcherbird manganese expansion from feasibility into project delivery, targeting mechanical completion and commissioning in the first quarter of calendar 2027. The company also strengthened funding and commercial support, although construction, financing conditions and the absence of FY2026 revenue leave execution as the central test.

WhiteHawk has secured an unsecured A$1.5 million facility and says it does not currently expect to raise equity, after cutting annualised operating costs by about A$1.24 million. The funding comes at a 16% interest rate and must be repaid in full at maturity, leaving execution and cash receipts central to the plan.

Enlitic has secured a US$806,000 contract to migrate 10.6 million medical imaging studies for University of Michigan Health-Sparrow. The project also gives its Ensight platform a first active integration with Sectra’s enterprise imaging environment.

Dateline Resources has gained a powerful ally in its bid to restart the Colosseum project, with the US Government asking a federal court to suspend the injunction blocking operations. A Department of War declaration argues the California rare earth project serves US economic and national security interests, but the stay remains undecided.